theranostics < therapeutic < therapeutics

Facettes :

List of bibliographic references indexed by therapeutic

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]

Ident.	Authors (with country if any)	Title
000065 (2017)	Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada]	Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
000510 (2015)	Gerald W. Zamponi ; Joerg Striessnig ; Alexandra Koschak ; Annette C. Dolphin	The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential
000539 (2015)	Lawrence Lin [États-Unis] ; Sook Wah Yee [États-Unis] ; Richard B. Kim [Canada] ; Kathleen M. Giacomini [États-Unis]	SLC Transporters as Therapeutic Targets: Emerging Opportunities
000623 (2015)	Ali H. Rajput [Canada] ; Michele L. Rajput [Canada] ; Christopher A. Robinson [Canada] ; Alex Rajput [Canada]	Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations.
000700 (2015)	Kyle Farmer ; Christopher Rudyk ; Natalie A. Prowse ; Shawn Hayley	Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease
000887 (2014)	Jamie Eberling [États-Unis] ; Lona Vincent [États-Unis] ; Jennifer G. Goldman ; Daniel Weintraub ; Jaime Kulisevsky ; Connie Marras ; Glenn Stebbins ; Karl Kieburtz	Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory Roundtable
000890 (2014)	Leonardo Cortez ; Valerie Sim	The therapeutic potential of chemical chaperones in protein folding diseases
000914 (2014)	Arabella Young ; Deepak Mittal ; John Stagg [Canada] ; Mark J. Smyth [Australie]	Targeting cancer-derived adenosine: new therapeutic approaches.
000967 (2014)	Lynda Peterson [États-Unis] ; Kathleen P. Ismond [Canada] ; Elisha Chapman [Canada] ; Patrick Flood [Canada, États-Unis]	Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinsonμs Disease
000A29 (2014)	Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada]	Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
000A82 (2014)	Willard W. Sharp ; Yong Hu Fang ; Mei Han ; Hannah J. Zhang ; Zhigang Hong [États-Unis] ; Alexandra Banathy ; Erik Morrow [États-Unis] ; John J. Ryan [États-Unis] ; Stephen L. Archer [États-Unis, Canada]	Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission
000C32 (2013)	Bernard Le Foll [Canada] ; Abhiram Pushparaj [Canada] ; Yaroslaw Pryslawsky [Canada] ; Benoit Forget [France] ; Kiran Vemuri [États-Unis] ; Alexandros Makriyannis [États-Unis] ; Jose M. Trigo [Canada]	Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach
000C93 (2013)	Khushwant S. Bhullar [Canada] ; H. P. Vasantha Rupasinghe [Canada]	Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases
000D03 (2013)	Roger F. Butterworth [Canada]	Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.
000D37 (2013)	Danielle Murray [Canada] ; A Jon Stoessl	Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
000F19 (2013)	Andrew B. Singleton [États-Unis] ; Matthew J. Farrer [Canada] ; Vincenzo Bonifati [Pays-Bas]	The genetics of Parkinson's disease: Progress and therapeutic implications
001059 (2013)	Danielle Murray [Canada] ; A. Jon Stoessl [Canada]	Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
001098 (2012)	Bo-Rim Yi [Corée du Sud] ; Kelvin J. Choi ; Seung U. Kim [Canada, Corée du Sud] ; Kyung-Chul Choi [Corée du Sud]	Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: Evidence that they exert tumoricidal effects via tumor tropism
001368 (2012)	Joana M. Gil-Mohapel [Canada]	Screening of Therapeutic Strategies for Huntington's Disease in YAC128 Transgenic Mice
001570 (2011)	Venkatramanujam Srinivasan	Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection
001571 (2011)	J P Little [Canada] ; E B Villanueva ; A. Klegeris	Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "therapeutic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "therapeutic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    therapeutic
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022